APO Research

APO RESEARCH · REPORT

Veterinary Infectious Disease Diagnosis

Selected research

Market Analysis & Forecast

Global Veterinary Infectious Disease Diagnosis Market Analysis and Forecast 2026-2032

Market perspective

The global Veterinary Infectious Disease Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Veterinary Infectious Disease Diagnosis include Thermo Fisher Scientific, Neogen Corporation, Virbac, IDVet, Randox Laboratories, Heska Corporation, Creative Diagnostics, Eurofins Technologies and IDEXX Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Veterinary Infectious Disease Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Infectious Disease Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Infectious Disease Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Infectious Disease Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Infectious Disease Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Infectious Disease Diagnosis revenue, projected growth trends, production technology, application and end-user industry.

Veterinary Infectious Disease Diagnosis Segment by Company

Thermo Fisher Scientific

Neogen Corporation

Virbac

IDVet

Randox Laboratories

Heska Corporation

Creative Diagnostics

Eurofins Technologies

IDEXX Laboratories

Zoetis

QIAGEN

Veterinary Infectious Disease Diagnosis Segment by Type

Molecular Diagnostics

Immunodiagnostics

Other Technologies

Veterinary Infectious Disease Diagnosis Segment by Application

Veterinary Laboratories

Clinics

Reference Laboratories

Research Institutes

Others

Veterinary Infectious Disease Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Infectious Disease Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Infectious Disease Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Infectious Disease Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Veterinary Infectious Disease Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Veterinary Infectious Disease Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Infectious Disease Diagnosis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Infectious Disease Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Molecular Diagnostics Major Player Table 3. Immunodiagnostics Major Player Table 4. Other Technologies Major Player Table 5. Global Veterinary Infectious Disease Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Veterinary Laboratories Major Player Table 7. Clinics Major Player Table 8. Reference Laboratories Major Player Table 9. Research Institutes Major Player Table 10. Others Major Player Table 11. Veterinary Infectious Disease Diagnosis Industry Trends Table 12. Veterinary Infectious Disease Diagnosis Industry Drivers Table 13. Veterinary Infectious Disease Diagnosis Industry Opportunities and Challenges Table 14. Veterinary Infectious Disease Diagnosis Industry Restraints Table 15. Global Veterinary Infectious Disease Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Veterinary Infectious Disease Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Veterinary Infectious Disease Diagnosis Market Share by Region (2021-2026) Table 18. Global Veterinary Infectious Disease Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Veterinary Infectious Disease Diagnosis Market Share by Region (2027-2032) Table 20. Global Veterinary Infectious Disease Diagnosis Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Players (2021-2026) Table 22. Global Veterinary Infectious Disease Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Veterinary Infectious Disease Diagnosis Key Players Headquarters & Area Served Table 24. Global Veterinary Infectious Disease Diagnosis Players, Product Type & Application Table 25. Global Veterinary Infectious Disease Diagnosis Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Veterinary Infectious Disease Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Veterinary Infectious Disease Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Type (2021-2026) Table 32. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Type (2027-2032) Table 33. Global Veterinary Infectious Disease Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Application (2021-2026) Table 37. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Application (2027-2032) Table 38. Thermo Fisher Scientific Company Information Table 39. Thermo Fisher Scientific Business Overview Table 40. Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Product Portfolio Table 42. Thermo Fisher Scientific Recent Development Table 43. Neogen Corporation Company Information Table 44. Neogen Corporation Business Overview Table 45. Neogen Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Neogen Corporation Veterinary Infectious Disease Diagnosis Product Portfolio Table 47. Neogen Corporation Recent Development Table 48. Virbac Company Information Table 49. Virbac Business Overview Table 50. Virbac Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Virbac Veterinary Infectious Disease Diagnosis Product Portfolio Table 52. Virbac Recent Development Table 53. IDVet Company Information Table 54. IDVet Business Overview Table 55. IDVet Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. IDVet Veterinary Infectious Disease Diagnosis Product Portfolio Table 57. IDVet Recent Development Table 58. Randox Laboratories Company Information Table 59. Randox Laboratories Business Overview Table 60. Randox Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Randox Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio Table 62. Randox Laboratories Recent Development Table 63. Heska Corporation Company Information Table 64. Heska Corporation Business Overview Table 65. Heska Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Heska Corporation Veterinary Infectious Disease Diagnosis Product Portfolio Table 67. Heska Corporation Recent Development Table 68. Creative Diagnostics Company Information Table 69. Creative Diagnostics Business Overview Table 70. Creative Diagnostics Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Creative Diagnostics Veterinary Infectious Disease Diagnosis Product Portfolio Table 72. Creative Diagnostics Recent Development Table 73. Eurofins Technologies Company Information Table 74. Eurofins Technologies Business Overview Table 75. Eurofins Technologies Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Eurofins Technologies Veterinary Infectious Disease Diagnosis Product Portfolio Table 77. Eurofins Technologies Recent Development Table 78. IDEXX Laboratories Company Information Table 79. IDEXX Laboratories Business Overview Table 80. IDEXX Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. IDEXX Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio Table 82. IDEXX Laboratories Recent Development Table 83. Zoetis Company Information Table 84. Zoetis Business Overview Table 85. Zoetis Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Zoetis Veterinary Infectious Disease Diagnosis Product Portfolio Table 87. Zoetis Recent Development Table 88. QIAGEN Company Information Table 89. QIAGEN Business Overview Table 90. QIAGEN Veterinary Infectious Disease Diagnosis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. QIAGEN Veterinary Infectious Disease Diagnosis Product Portfolio Table 92. QIAGEN Recent Development Table 93. North America Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 99. North America Veterinary Infectious Disease Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 100. Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Veterinary Infectious Disease Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 107. China Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 108. China Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 109. China Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 110. China Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 112. Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 113. Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 114. Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Veterinary Infectious Disease Diagnosis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Veterinary Infectious Disease Diagnosis Revenue by Region (US$ Million) & (2021-2026) Table 117. Asia Veterinary Infectious Disease Diagnosis Revenue by Region (US$ Million) & (2027-2032) Table 118. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 119. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 120. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 121. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 122. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 124. SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Veterinary Infectious Disease Diagnosis Image Figure 2. Global Veterinary Infectious Disease Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Infectious Disease Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Molecular Diagnostics Image Figure 5. Immunodiagnostics Image Figure 6. Other Technologies Image Figure 7. Global Veterinary Infectious Disease Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Veterinary Infectious Disease Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 9. Veterinary Laboratories Image Figure 10. Clinics Image Figure 11. Reference Laboratories Image Figure 12. Research Institutes Image Figure 13. Others Image Figure 14. Global Veterinary Infectious Disease Diagnosis Market Size (US$ Million) & (2021-2032) Figure 15. Global Veterinary Infectious Disease Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Infectious Disease Diagnosis Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Infectious Disease Diagnosis Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Veterinary Infectious Disease Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Veterinary Infectious Disease Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Type (2021-2032) Figure 22. Global Veterinary Infectious Disease Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Application (2021-2032) Figure 25. North America Veterinary Infectious Disease Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032) Figure 27. North America Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032) Figure 28. North America Veterinary Infectious Disease Diagnosis Revenue Share by Country (2021-2032) Figure 29. United States Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Veterinary Infectious Disease Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032) Figure 34. Europe Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032) Figure 35. Europe Veterinary Infectious Disease Diagnosis Revenue Share by Country (2021-2032) Figure 36. Germany Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Veterinary Infectious Disease Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032) Figure 46. China Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032) Figure 47. Asia Veterinary Infectious Disease Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032) Figure 49. Asia Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032) Figure 50. Asia Veterinary Infectious Disease Diagnosis Revenue Share by Region (2021-2032) Figure 51. Japan Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Veterinary Infectious Disease Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032) Figure 59. SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032) Figure 60. SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Country (2021-2032) Figure 61. Brazil Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Veterinary Infectious Disease Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Diagnostics
  • Immunodiagnostics
  • Other Technologies
Applications
  • Veterinary Laboratories
  • Clinics
  • Reference Laboratories
  • Research Institutes
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Neogen Corporation
  • Virbac
  • IDVet
  • Randox Laboratories
  • Heska Corporation
  • Creative Diagnostics
  • Eurofins Technologies
  • IDEXX Laboratories
  • Zoetis
  • QIAGEN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Infectious Disease Diagnosis Market by Type
  3. 1.2.1 Global Veterinary Infectious Disease Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Molecular Diagnostics
  5. 1.2.3 Immunodiagnostics
  6. 1.2.4 Other Technologies
  7. 1.3 Veterinary Infectious Disease Diagnosis Market by Application
  8. 1.3.1 Global Veterinary Infectious Disease Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Veterinary Laboratories
  10. 1.3.3 Clinics
  11. 1.3.4 Reference Laboratories
  12. 1.3.5 Research Institutes
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Veterinary Infectious Disease Diagnosis Market Dynamics
  1. 2.1 Veterinary Infectious Disease Diagnosis Industry Trends
  2. 2.2 Veterinary Infectious Disease Diagnosis Industry Drivers
  3. 2.3 Veterinary Infectious Disease Diagnosis Industry Opportunities and Challenges
  4. 2.4 Veterinary Infectious Disease Diagnosis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Veterinary Infectious Disease Diagnosis Market Perspective (2021-2032)
  2. 3.2 Global Veterinary Infectious Disease Diagnosis Growth Trends by Region
  3. 3.2.1 Global Veterinary Infectious Disease Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Infectious Disease Diagnosis Market Size by Region (2021-2026)
  5. 3.2.3 Global Veterinary Infectious Disease Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Veterinary Infectious Disease Diagnosis Revenue by Players
  2. 4.1.1 Global Veterinary Infectious Disease Diagnosis Revenue by Players (2021-2026)
  3. 4.1.2 Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Veterinary Infectious Disease Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Infectious Disease Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Veterinary Infectious Disease Diagnosis Key Players Headquarters & Area Served
  7. 4.4 Global Veterinary Infectious Disease Diagnosis Players, Product Type & Application
  8. 4.5 Global Veterinary Infectious Disease Diagnosis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Veterinary Infectious Disease Diagnosis Market CR5 and HHI
  11. 4.6.3 2025 Veterinary Infectious Disease Diagnosis Tier 1, Tier 2, and Tier 3
5 Veterinary Infectious Disease Diagnosis Market Size by Type
  1. 5.1 Global Veterinary Infectious Disease Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
  3. 5.3 Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Type (2021-2032)
6 Veterinary Infectious Disease Diagnosis Market Size by Application
  1. 6.1 Global Veterinary Infectious Disease Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
  3. 6.3 Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Neogen Corporation
  8. 7.2.1 Neogen Corporation Company Information
  9. 7.2.2 Neogen Corporation Business Overview
  10. 7.2.3 Neogen Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Neogen Corporation Veterinary Infectious Disease Diagnosis Product Portfolio
  12. 7.2.5 Neogen Corporation Recent Developments
  13. 7.3 Virbac
  14. 7.3.1 Virbac Company Information
  15. 7.3.2 Virbac Business Overview
  16. 7.3.3 Virbac Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Virbac Veterinary Infectious Disease Diagnosis Product Portfolio
  18. 7.3.5 Virbac Recent Developments
  19. 7.4 IDVet
  20. 7.4.1 IDVet Company Information
  21. 7.4.2 IDVet Business Overview
  22. 7.4.3 IDVet Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 IDVet Veterinary Infectious Disease Diagnosis Product Portfolio
  24. 7.4.5 IDVet Recent Developments
  25. 7.5 Randox Laboratories
  26. 7.5.1 Randox Laboratories Company Information
  27. 7.5.2 Randox Laboratories Business Overview
  28. 7.5.3 Randox Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Randox Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio
  30. 7.5.5 Randox Laboratories Recent Developments
  31. 7.6 Heska Corporation
  32. 7.6.1 Heska Corporation Company Information
  33. 7.6.2 Heska Corporation Business Overview
  34. 7.6.3 Heska Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Heska Corporation Veterinary Infectious Disease Diagnosis Product Portfolio
  36. 7.6.5 Heska Corporation Recent Developments
  37. 7.7 Creative Diagnostics
  38. 7.7.1 Creative Diagnostics Company Information
  39. 7.7.2 Creative Diagnostics Business Overview
  40. 7.7.3 Creative Diagnostics Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Diagnostics Veterinary Infectious Disease Diagnosis Product Portfolio
  42. 7.7.5 Creative Diagnostics Recent Developments
  43. 7.8 Eurofins Technologies
  44. 7.8.1 Eurofins Technologies Company Information
  45. 7.8.2 Eurofins Technologies Business Overview
  46. 7.8.3 Eurofins Technologies Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eurofins Technologies Veterinary Infectious Disease Diagnosis Product Portfolio
  48. 7.8.5 Eurofins Technologies Recent Developments
  49. 7.9 IDEXX Laboratories
  50. 7.9.1 IDEXX Laboratories Company Information
  51. 7.9.2 IDEXX Laboratories Business Overview
  52. 7.9.3 IDEXX Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 IDEXX Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio
  54. 7.9.5 IDEXX Laboratories Recent Developments
  55. 7.10 Zoetis
  56. 7.10.1 Zoetis Company Information
  57. 7.10.2 Zoetis Business Overview
  58. 7.10.3 Zoetis Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Zoetis Veterinary Infectious Disease Diagnosis Product Portfolio
  60. 7.10.5 Zoetis Recent Developments
  61. 7.11 QIAGEN
  62. 7.11.1 QIAGEN Company Information
  63. 7.11.2 QIAGEN Business Overview
  64. 7.11.3 QIAGEN Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 QIAGEN Veterinary Infectious Disease Diagnosis Product Portfolio
  66. 7.11.5 QIAGEN Recent Developments
8 North America
  1. 8.1 North America Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
  2. 8.2 North America Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
  3. 8.2.1 North America Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
  4. 8.2.2 North America Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
  5. 8.3 North America Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
  6. 8.4 North America Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
  7. 8.4.1 North America Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
  8. 8.4.2 North America Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
  9. 8.5 North America Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
  10. 8.6 North America Veterinary Infectious Disease Diagnosis Revenue by Country
  11. 8.6.1 North America Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
  13. 8.6.3 North America Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
  2. 9.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
  5. 9.3 Europe Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
  9. 9.5 Europe Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Veterinary Infectious Disease Diagnosis Revenue by Country
  11. 9.6.1 Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
  2. 10.2 China Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
  3. 10.2.1 China Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
  4. 10.2.2 China Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
  5. 10.3 China Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
  6. 10.4 China Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
  7. 10.4.1 China Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
  8. 10.4.2 China Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
  9. 10.5 China Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
  2. 11.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
  5. 11.3 Asia Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
  9. 11.5 Asia Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Veterinary Infectious Disease Diagnosis Revenue by Country
  11. 11.6.1 Asia Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
  2. 12.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country
  11. 12.6.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research